ArticleBMC nephrology2026

Cost-utility analysis of sodium-glucose cotransporter-2 inhibitors on chronic kidney disease progression in patients with type 2 diabetes mellitus.

Sukanya Siriyotha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.